|
| Status |
Public on Dec 15, 2006 |
| Title |
3BSA H |
| Sample type |
RNA |
| |
|
| Source name |
662
|
| Organism |
Mus musculus |
| Characteristics |
stage: E15.5
organ: tibiae
mouse strain: CD1
gender: male and female
|
| Biomaterial provider |
Charles River
|
| Treatment protocol |
vehicle: BSA/HCL 1.0 Mm
|
| Growth protocol |
6 days in minimal media
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Qiagen RNeasy lipid extraction kit
|
| Label |
SAPE
|
| Label protocol |
According to standard protocols used in London Regional Genomics Facility. Ontario, Canada
|
| |
|
| Hybridization protocol |
According to standard protocols used in London Regional Genomics Facility. Ontario, Canada
|
| Scan protocol |
According to standard protocols used in London Regional Genomics Facility. Ontario, Canada
|
| Description |
culture time: 6 days
media: minimal
treatment regime: treat on days 1, 3 and 5
microdissect: day 6
number of tibiae per treatment: 24
|
| Data processing |
Gene Spring GX
|
| |
|
| Submission date |
Mar 13, 2006 |
| Last update date |
Aug 28, 2018 |
| Contact name |
Claudine James |
| E-mail(s) |
claudinegj@hotmail.com, fbeier@uwo.ca
|
| Phone |
(519)661-3387
|
| Fax |
(519)850-2459
|
| Organization name |
University of Western Ontario
|
| Department |
Physiology and Pharmacology
|
| Lab |
Frank Beier/ CIHR Group in Skeletal Development and Remodeling
|
| Street address |
1151 Richmond Street, Suite 2
|
| City |
London |
| State/province |
Ontario |
| ZIP/Postal code |
N6A 5C1 |
| Country |
Canada |
| |
|
| Platform ID |
GPL1261 |
| Series (1) |
| GSE4481 |
C-type natriuretic peptide regulates endochondral ossification through p38 MAP kinase-dependent pathways_2 |
|
| Relations |
| Reanalyzed by |
GSE119085 |
